Generic Kaletra is not yet available. As soon as the patents for the individual components of the medication expire in June 2016, several companies are expected to begin producing generic versions of it. Until an approved version is actually available, do not purchase any so-called "generic Kaletra," because these products may be fake, substandard, and dangerous.
Generic Kaletra: An Overview
Kaletra® (lopinavir and ritonavir) is a prescription AIDS and HIV medication. It belongs to a class of medications known as protease inhibitors. It actually contains two different protease inhibitors: lopinavir and ritonavir. Ritonavir is used to increase the level of lopinavir in the blood, helping it work better.
Kaletra is made by Abbott Laboratories. It is currently under the protection of patents that prevent any generic Kaletra from being manufactured in the United States. Yet, if you search the Internet for "generic Kaletra," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Kaletra may be available from another country, but there is really no way of knowing if you are getting genuine Kaletra. You should not buy any generic Kaletra until there is an approved version available.
When Will Generic Kaletra Be Available?
There are many different patents listed for Kaletra. Some may apply to the individual components (lopinavir or ritonavir), while others may apply to the combination of the two. It is difficult to predict when exactly a generic version of Kaletra may become available. The situation is very confusing due to the various patents for ritonavir, lopinavir, or the combination of the two.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Kaletra [package insert]. North Chicago, IL: Abbott Laboratories;2013 January.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed June 5, 2009.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click